Sociedad Americana de Hirudoterapia

Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech

Basic science published in Platelets (2000)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportFarmacología salivalDesarrollo de fármacosBaskova I et al. · Platelets, 2000

Abstract

Destabilase, endo-epsilon-(gamma-Glu)-Lys isopeptidase from the medicinal leech, inhibits arterial thrombus formation in rats. Inhibition of platelet aggregation was supposed to be one of the main mechanisms of this phenomenon. To elucidate this question highly purified destabilase preparations were used. Aggregation was monitored both by a turbidometric method and by a method based on real-time estimation of mean aggregate size. Spontaneous aggregation of human platelets was completely blocked by destabilase. At 5 microM ADP maximal inhibition was 63%. Aggregation induced by PAF (100 nM) and collagen (0.1 mg/ml) was inhibited in the presence of destabilase by 50 and 65%, respectively. This enzyme does not activate adenylate cyclase but inhibits it. We suggest that destabilase interacts with high-affinity binding sites on the platelet plasma membrane, thus providing an anti-aggregating effect. This idea coincides with the data that destabilase primary structure has high homology with some adhesive proteins.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdenosine DiphosphateAdenylyl CyclasesAlprostadilAnimalsBlood PlateletsCardiovascular DiseasesCollagenDose-Response Relationship, DrugEndopeptidasesFibrinolytic AgentsHumansLeeches

Resumen

Destabilase completely blocks spontaneous human platelet aggregation and reduces ADP-, PAF-, and collagen-induced aggregation by 50-65%, likely via plasma membrane high-affinity binding sites.

Por qué esto importa para la hirudoterapia

This study investigated destabilase, an isopeptidase from the medicinal leech that inhibits arterial thrombus formation in rats, focusing on its antiplatelet mechanisms using highly purified preparations monitored by turbidometric and real-time aggregation methods. The findings are relevant to understanding the leech secretome, as destabilase completely blocked spontaneous human platelet aggregation and inhibited ADP-induced aggregation by up to 63%, PAF-induced by 50%, and collagen-induced by 65%. The authors propose that destabilase interacts with high-affinity binding sites on platelet plasma membranes and note its structural homology with adhesive proteins. The study encompasses both in vivo rat thrombosis findings and in vitro human platelet experiments, though no clinical

Citación

Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech.

Baskova I et al. · Platelets, 2000

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.